Document is current

Any future updates will be listed below

Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months

Crossref DOI link: https://doi.org/10.1186/s40164-017-0067-4

Published Online: 2017-03-21

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark